{"podcast":{"title":"Gynecologic Oncology Update","slug":"gynecologic-oncology-update-612940","podcast_index_feed_id":612940,"rss_url":"https://feeds.captivate.fm/gynecologic-oncology/","website_url":"https://www.researchtopractice.com/browse-tumor-types/ovarian-cancer","image_url":"https://artwork.captivate.fm/aa2bde68-0d40-4e41-b73e-fff33f9524cf/gou-podcast-logo-3000px.png","author":"Dr. Neil Love","episode_count":46,"summary":"This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.","last_synced_at":"2026-07-21T08:21:50.117078+00:00","page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940"},"episode":{"title":"Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer","slug":"antibody-drug-conjugates-in-gynecologic-cancers-proceedings-from-a-session-held-during-the-society-of-gynecologic-oncology-2026-annual-meeting-on-women-s-cancer","published_at":"2026-06-03T21:00:00+00:00","page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940/antibody-drug-conjugates-in-gynecologic-cancers-proceedings-from-a-session-held-during-the-society-of-gynecologic-oncology-2026-annual-meeting-on-women-s-cancer","show_page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940","url":"https://gynecologic-oncology.captivate.fm/episode/5842-sgo2026-adcsgyn","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/95ef760d-7360-4747-9346-a162e533142d.mp3","summary":"Prof Ramez N Eskander from UC San Diego Moores Cancer Center in California, Dr Bradley J Monk from Florida Cancer Specialists & Research Institute in West Palm Beach and Dr Kathleen N Moore from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, review the treatment landscape of antibody-drug conjugate–directed therapy for gynecologic cancers and review recently presented clinical findings from the SGO 2026 Annual Meeting on Women’s Cancer. CME information and select publications","meta_description":"Prof Ramez N Eskander from UC San Diego Moores Cancer Center in California, Dr Bradley J Monk from Florida Cancer Specialists & Research Institute in…","key_points":[],"chapters":[],"topics":[],"duration_seconds":5475,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/antibody-drug-conjugates-in-gynecologic-cancers-proceedings-from-a-session-held-during-the-society-of-gynecologic-oncology-2026-annual-meeting-on-women-s-cancer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940/antibody-drug-conjugates-in-gynecologic-cancers-proceedings-from-a-session-held-during-the-society-of-gynecologic-oncology-2026-annual-meeting-on-women-s-cancer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}